Linaclotide for treating patients with irritable bowel syndrome with predominant constipation: a multicentre study of real-world data in China

Liu, L; Zhang, WH; Zhao, W; Guo, S; Wang, YJ; Lv, XJ; Li, B; Wang, HP; Xu, EB; Li, Q; Zhu, Q; Gou, XB; Zhao, WD; Guo, JQ

Guo, JQ (通讯作者)，Shandong Univ, Hosp 2, Dept Gastroenterol, 247 Beiyuan St, Jinan, Shandong, Peoples R China.

THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2022; 15 ():

Abstract

Introduction: Linaclotide, a guanylate cyclase C agonist that improves the symptoms of irritable bowel syndrome with predominant constipation (IBS-C),......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索